Hill-Rom Holdings Inc (HRC) SVP Andreas G. Frank Sells 3,940 Shares of Stock

Hill-Rom Holdings Inc (NYSE:HRC) SVP Andreas G. Frank sold 3,940 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total value of $306,689.60. Following the completion of the sale, the senior vice president now owns 16,701 shares of the company’s stock, valued at approximately $1,300,005.84. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Hill-Rom Holdings Inc (HRC) traded down 1.81% on Friday, hitting $75.60. The stock had a trading volume of 1,612,576 shares. Hill-Rom Holdings Inc has a 12-month low of $50.50 and a 12-month high of $84.65. The company has a market capitalization of $4.98 billion, a PE ratio of 44.06 and a beta of 1.21. The company has a 50 day moving average of $75.30 and a 200 day moving average of $75.12.

Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.01. The business had revenue of $689.10 million during the quarter, compared to the consensus estimate of $695.50 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. Hill-Rom Holdings’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.81 earnings per share. On average, equities analysts expect that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be issued a $0.18 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.72 dividend on an annualized basis and a yield of 0.95%. Hill-Rom Holdings’s payout ratio is 41.62%.

ILLEGAL ACTIVITY NOTICE: “Hill-Rom Holdings Inc (HRC) SVP Andreas G. Frank Sells 3,940 Shares of Stock” was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.chaffeybreeze.com/2017/09/16/hill-rom-holdings-inc-hrc-svp-andreas-g-frank-sells-3940-shares-of-stock.html.

Institutional investors have recently modified their holdings of the business. Independent Portfolio Consultants Inc. grew its holdings in Hill-Rom Holdings by 171.5% during the 2nd quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock worth $107,000 after acquiring an additional 849 shares during the period. Meadow Creek Investment Management LLC grew its holdings in Hill-Rom Holdings by 3.9% during the 1st quarter. Meadow Creek Investment Management LLC now owns 1,696 shares of the medical technology company’s stock worth $120,000 after acquiring an additional 64 shares during the period. Seven Eight Capital LP acquired a new stake in Hill-Rom Holdings during the 2nd quarter worth about $127,000. Acrospire Investment Management LLC grew its holdings in Hill-Rom Holdings by 43.4% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,983 shares of the medical technology company’s stock worth $158,000 after acquiring an additional 600 shares during the period. Finally, Neuburgh Advisers LLC grew its holdings in Hill-Rom Holdings by 3.9% during the 1st quarter. Neuburgh Advisers LLC now owns 2,332 shares of the medical technology company’s stock worth $165,000 after acquiring an additional 88 shares during the period. Hedge funds and other institutional investors own 82.31% of the company’s stock.

A number of equities analysts have recently issued reports on the company. Zacks Investment Research raised Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $86.00 target price for the company in a report on Friday, May 26th. BidaskClub cut Hill-Rom Holdings from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Cantor Fitzgerald assumed coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They issued a “neutral” rating and a $86.00 target price for the company. Stifel Nicolaus reissued a “buy” rating and issued a $84.00 target price on shares of Hill-Rom Holdings in a report on Sunday, July 30th. Finally, Needham & Company LLC assumed coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They issued a “buy” rating and a $95.00 target price for the company. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $88.17.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Insider Buying and Selling by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply